Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.83 USD | -1.16% | +3.02% | -20.67% |
May. 08 | Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral | MT |
May. 03 | UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating | MT |
Evolution of the average Target Price on Alignment Healthcare, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Alignment Healthcare, Inc.
Piper Sandler | |
UBS | |
Stifel Nicolaus | |
Stephens Inc. | |
BofA Securities | |
Raymond James | |
Morgan Stanley | |
JPMorgan Chase | |
Goldman Sachs | |
Cowen | |
Barclays | |
SVB Leerink | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- ALHC Stock
- Consensus Alignment Healthcare, Inc.